Short running title: allo SCT for MDS with bone marrow fibrosis

[1]  M. Werner,et al.  Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. , 2009, European journal of haematology.

[2]  M. Cazzola,et al.  Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Ganser,et al.  Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes , 2008, Leukemia.

[4]  B. Storer,et al.  Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  Luca Malcovati,et al.  Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Steensma,et al.  Myelodysplasia with fibrosis: a distinct entity? , 2001, Leukemia research.

[7]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[8]  R. Storb,et al.  Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment. , 1995, Blood.

[9]  D. Soligo,et al.  Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes , 1993, Annals of Hematology.

[10]  J. Reilly,et al.  Characterization of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis , 1993, British journal of haematology.

[11]  C. Wolf‐peeters,et al.  Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features , 1991, Annals of Hematology.

[12]  R. Luksch,et al.  Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico‐pathological entity , 1991, British journal of haematology.

[13]  H. Deeg,et al.  Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation. , 1986, Blood.

[14]  V. Cemerikić,et al.  Myelofibrosis in primary myelodysplastic syndromes , 2004, Medical oncology.

[15]  O. Katoh,et al.  Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. , 1989, British journal of haematology.